TAK1 inhibition leads to RIPK1-dependent apoptosis in immune-activated cancers
Open Access
- 17 April 2024
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 15 (4) , 1-17
Abstract
Poor survival and lack of treatment response in glioblastoma (GBM) is attributed to the persistence of glioma stem cells (GSCs). To identify novel therapeutic approaches, we performed CRISPR/Cas9 knockout screens and discovered TGFβ activated kinase (TAK1) as a selective survival factor in a significant fraction of GSCs. Loss of TAK1 kinase activity results in RIPK1-dependent apoptosis via Caspase-8/FADD complex activation, dependent on autocrine TNFα ligand production and constitutive TNFR signaling. We identify a transcriptional signature associated with immune activation and the mesenchymal GBM subtype to be a characteristic of cancer cells sensitive to TAK1 perturbation and employ this signature to accurately predict sensitivity to the TAK1 kinase inhibitor HS-276. In addition, exposure to pro-inflammatory cytokines IFNγ and TNFα can sensitize resistant GSCs to TAK1 inhibition. Our findings reveal dependency on TAK1 kinase activity as a novel vulnerability in immune-activated cancers, including mesenchymal GBMs that can be exploited therapeutically.Keywords
This publication has 60 references indexed in Scilit:
- Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasionCell, 2021
- Mesenchymal Transformation: The Rosetta Stone of Glioblastoma Pathogenesis and Therapy ResistanceAdvanced Science, 2020
- An Integrative Model of Cellular States, Plasticity, and Genetics for GlioblastomaCell, 2019
- Takinib, a Selective TAK1 Inhibitor, Broadens the Therapeutic Efficacy of TNF-α Inhibition for Cancer and Autoimmune DiseaseCell Chemical Biology, 2017
- Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the MicroenvironmentCancer Cell, 2017
- Clonal Variation in Drug and Radiation Response among Glioma-Initiating Cells Is Linked to Proneural-Mesenchymal TransitionCell Reports, 2016
- The Molecular Signatures Database Hallmark Gene Set CollectionCell Systems, 2015
- The Human Glioblastoma Cell Culture Resource: Validated Cell Models Representing All Molecular SubtypesEBioMedicine, 2015
- Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in GlioblastomaCancer Cell, 2013
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010